Viewing Study NCT03920657


Ignite Creation Date: 2025-12-24 @ 6:49 PM
Ignite Modification Date: 2026-01-31 @ 1:08 AM
Study NCT ID: NCT03920657
Status: TERMINATED
Last Update Posted: 2022-11-21
First Post: 2018-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Early and Low Dose Deferasirox (3.5 mg/kg FCT) to Suppress NTBI and LPI as Early Intervention to Prevent Tissue Iron Overload in Lower Risk MDS
Sponsor: Fondazione Italiana Sindromi Mielodisplastiche-ETS
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDS View